Home › Hidradenitis Suppurativa › Michigan
Pag-aaral pangklinika para sa Hidradenitis Suppurativa sa Michigan
6 pag-aaral para sa Hidradenitis Suppurativa ang naghahanap ng mga kalahok sa mga site sa Michigan.
Mga Lungsod sa Michigan
Opisyal na teksto ng pag-aaral (English)
ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
- Oruka Therapeutics Investigative Site, Canton
Nagre-recruitPhase 2
Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07783542Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US061, Ann Arbor
- Investigative Site US120, Detroit
- Investigative Site US091, Troy
- at 1 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06855498Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- Oakland Hills Dermatology Pc, Auburn Hills
- Wayne State University Physician Group Dermatology, Detroit
- Revival Research Institute, Llc Troy, Troy
Nagre-recruitPhase 2
Edad 12 hanggang 17 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07213973A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
- Wayne State University, Detroit
- Hamzavi Dermatology, Fort Gratiot
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 6, 2026 · NCT07244263A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab
- University of Michigan Health System - Ann Arbor /ID# 267275, Ann Arbor
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ene 24, 2025 · NCT06524635Battlefield Acupuncture for Pain in Hidradenitis Suppurativa
- WSUPG Dermatology, Dearborn
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update May 16, 2023 · NCT04218422Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.